Markedly increased incidence and improved survival of testicular cancer in the Netherlands

Authors

  • Rob H. A. Verhoeven Eindhoven Cancer Registry/Comprehensive Cancer Centre South, Eindhoven, The Netherlands
  • Henrike E. Karim-Kos Department of Public Health, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands
  • Jan Willem W. Coebergh Eindhoven Cancer Registry/Comprehensive Cancer Centre South, Eindhoven, The Netherlands; Department of Public Health, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands
  • Mirian Brink Comprehensive Cancer Centre the Netherlands, Utrecht, The Netherlands
  • Simon Horenblas Department of Urology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
  • Ronald de Wit Department of Medical Oncology, Erasmus MC University Medical Centre Rotterdam/Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
  • Bart A. L. M. Kiemeney Comprehensive Cancer Centre the Netherlands, Utrecht, The Netherlands;Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands

DOI:

https://doi.org/10.3109/0284186X.2013.819992

Abstract

Background. Worldwide marked changes have been observed in the incidence and survival of testicular cancer (TC) during the last decades. We conducted a study on trends in TC incidence, treatment, survival, and mortality in the Netherlands during the period 1970–2009 with specific focus on trends according to age, histology and stage of disease. Methods. Data from the Eindhoven cancer registry, the Netherlands cancer registry and Statistics Netherlands was used. Age-standardized incidence and mortality rates and five-year relative survival were calculated. Treatment was categorized into five major groups. Results. TC incidence showed a substantial annual increase of 3.9% in the period 1989–2009. The incidence increased for all stages of both seminoma and non-seminoma TC. Stage distribution for the non-seminoma patients shifted towards more localized disease. Most patients received primary treatment according to the guidelines. Five-year relative survival improved (non-significantly) for most groups of stage and histology. TC mortality dropped sharply in the 1970s and 1980s and remained relatively stable thereafter. Conclusion. This study shows that incidence of TC has increased sharply in the Netherlands. Relative survival is high and improved in most disease stages. There is a growing demand for medical care of newly diagnosed TC patients and for the rapidly increasing number of prevalent TC patients.

Downloads

Download data is not yet available.

Downloads

Published

2014-03-01

How to Cite

Verhoeven, R. H. A., Karim-Kos, H. E., Coebergh, J. W. W., Brink, M., Horenblas, S., de Wit, R., & Kiemeney, B. A. L. M. (2014). Markedly increased incidence and improved survival of testicular cancer in the Netherlands. Acta Oncologica, 53(3), 342–350. https://doi.org/10.3109/0284186X.2013.819992